相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of Endothelial Dysfunction and Endocan in Atherosclerosis: Point of Origin or End Point?
Ugur Canpolat et al.
ANGIOLOGY (2020)
ESM-1 promotes adhesion between monocytes and endothelial cells under intermittent hypoxia
Haili Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets
Giane Favretto et al.
TOXINS (2019)
Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis
Sandeep Kumar et al.
VASCULAR PHARMACOLOGY (2019)
TGF-β Signaling in Control of Cardiovascular Function
Marie-Jose Goumans et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease
Ricardo Castro-Ferreira et al.
ANNALS OF VASCULAR SURGERY (2018)
Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta
Barbora Vitverova et al.
ATHEROSCLEROSIS (2018)
Concentration and value of endocan on outcome in adult patients after severe sepsis
Sheng-Yuan Hsiao et al.
CLINICA CHIMICA ACTA (2018)
The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease A meta-analysis
Tianming Zhao et al.
MEDICINE (2018)
The role of biomarkers of endothelial activation in predicting morbidity and mortality in patients with severe sepsis and septic shock in intensive care: A prospective observational study
Yingying Fang et al.
THROMBOSIS RESEARCH (2018)
Endocan Concentration in Patients With Primary Hypertension
Dominika Musialowska et al.
ANGIOLOGY (2018)
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
Nathalie De Freitas Caires et al.
CRITICAL CARE (2018)
Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus
Ilhan Balamir et al.
ANGIOLOGY (2018)
Admission Endocan Level may be a Useful Predictor for In-Hospital Mortality and Coronary Severity Index in Patients With ST-Segment Elevation Myocardial Infarction
Harun Kundi et al.
ANGIOLOGY (2017)
Targeting vascular (endothelial) dysfunction
Andreas Daiber et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
CORP: Ultrasound assessment of vascular function with the passive leg movement technique
Jayson R. Gifford et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Soluble endoglin modulates the pro-inflammatory mediators NF-κB and IL-6 in cultured human endothelial cells
Michala Varejckova et al.
LIFE SCIENCES (2017)
Endothelial Cell-Derived Microparticles from Patients with Obstructive Sleep Apnea Hypoxia Syndrome and Coronary Artery Disease Increase Aortic Endothelial Cell Dysfunction
Lixin Jia et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus
Yaya Lv et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)
Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea
Nejat Altintas et al.
ANGIOLOGY (2016)
Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study
Paul Balanescu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2016)
Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina
Tolga Cimen et al.
ANGIOLOGY (2016)
Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus
Abdullah Icli et al.
ANGIOLOGY (2016)
Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players
Nicoleta Alexandru et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim
Adem Gungor et al.
ENDOCRINE RESEARCH (2016)
High Levels of Soluble Endoglin Induce a Proinflammatory and Oxidative-Stress Phenotype Associated with Preserved NO-Dependent Vasodilatation in Aortas from Mice Fed a High-Fat Diet
Katerina Jezkova et al.
JOURNAL OF VASCULAR RESEARCH (2016)
Microparticles as new markers of cardiovascular risk in diabetes and beyond
Francesca Santilli et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Soluble Endoglin Level Increase Occurs Prior to Development of Subclinical Structural Vascular Alterations in Diabetic Adolescents
Hamdi Cihan Emeksiz et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2016)
Endocan and Endothelial Dysfunction
Mustafa Aparci et al.
ANGIOLOGY (2015)
Endocan: A novel inflammatory indicator in cardiovascular disease?
Sevket Balta et al.
ATHEROSCLEROSIS (2015)
Association of endothelial microparticle with NO, eNOS, ET-1, and fractional flow reserve in patients with coronary intermediate lesions
Rui Song et al.
BIOMARKERS (2015)
Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension
Xiang-sheng Wang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2015)
Towards a comprehensive endothelial biomarkers profiling and endothelium-guided pharmacotherapy
Maria Walczak et al.
PHARMACOLOGICAL REPORTS (2015)
A reliable marker of vascular function: Does it exist?
Andrew D. Blann
TRENDS IN CARDIOVASCULAR MEDICINE (2015)
Oscillating glucose and constant high glucose induce endoglin expression in endothelial cells: the role of oxidative stress
Lucia La Sala et al.
ACTA DIABETOLOGICA (2015)
Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study
Murat Kose et al.
ANGIOLOGY (2015)
Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease
Jing Chen et al.
PLOS ONE (2015)
Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjogren's syndrome: new markers of chronic endothelial damage?
Elena Bartoloni et al.
RHEUMATOLOGY (2015)
Can biomarkers help us to better diagnose and manage sepsis?
Philipp Schuetz et al.
DIAGNOSIS (2015)
CD51+ endothelial microparticles as a biomarker of endothelial dysfunction in obese patients with hypertension
Shuai-Shuai Hu et al.
ENDOCRINE (2015)
Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus
Ben Parker et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Quantification of Endothelial Microparticles on Modified Cytometric Bead Assay and Prognosis in Chest Pain Patients
Yuqi Fan et al.
CIRCULATION JOURNAL (2014)
Esm1 Modulates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF Bioavailability
Susana F. Rocha et al.
CIRCULATION RESEARCH (2014)
Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In Vivo
Wonhwa Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Endocan is useful biomarker of survival and severity in sepsis
Dunja M. Mihajlovic et al.
MICROVASCULAR RESEARCH (2014)
Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease
Mahmut I. Yilmaz et al.
KIDNEY INTERNATIONAL (2014)
The Effects of Smoking on Levels of Endothelial Progenitor Cells and Microparticles in the Blood of Healthy Volunteers
Fariborz Mobarrez et al.
PLOS ONE (2014)
Small-Size Circulating Endothelial Microparticles in Coronary Artery Disease
Shuai-Shuai Hu et al.
PLOS ONE (2014)
Contrasting Roles of Different Endoglin Forms in Atherosclerosis
Young-Saeng Jang et al.
Immune Network (2014)
Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes
Silvia Montoro-Garcia et al.
ATHEROSCLEROSIS (2013)
Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction
Pil-Ki Min et al.
ATHEROSCLEROSIS (2013)
Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease
I. Balta et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis
Rouyanne T. Ras et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
BIOMARKERS OF ENDOTHELIAL CELL ACTIVATION IN EARLY SEPSIS
Simon Skibsted et al.
SHOCK (2013)
MicroRNAs in Endothelial Senescence and Atherosclerosis
Rossella Menghini et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2013)
Endothelial microparticles: missing link in endothelial dysfunction?
Pearly J. A. Yong et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)
The role of endoglin in atherosclerosis
Petr Nachtigal et al.
ATHEROSCLEROSIS (2012)
Expression and distribution of endocan in human tissues
S. M. Zhang et al.
BIOTECHNIC & HISTOCHEMISTRY (2012)
Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases
Tomokazu Ikemoto et al.
HEART AND VESSELS (2012)
Plasma Endothelial Microparticles and Their Correlation With the Presence of Hypertension and Arterial Stiffness in Patients With Type 2 Diabetes
Yinghua Chen et al.
JOURNAL OF CLINICAL HYPERTENSION (2012)
Endothelial Microparticles (EMP) for the Assessment of Endothelial Function: An In Vitro and In Vivo Study on Possible Interference of Plasma Lipids
Sabrina H. van Ierssel et al.
PLOS ONE (2012)
Circulating CD62E+ Microparticles and Cardiovascular Outcomes
Soon-Tae Lee et al.
PLOS ONE (2012)
Microparticles as mediators and biomarkers of rheumatic disease
David S. Pisetsky et al.
RHEUMATOLOGY (2012)
The Many Faces of Endothelial Microparticles
Francoise Dignat-George et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?
Patrick Paulus et al.
BIOMARKERS (2011)
Risk of Macrovascular Complications in Type 2 Diabetes Mellitus: Endothelial Microparticle Profiles
Keun-Hwa Jung et al.
CEREBROVASCULAR DISEASES (2011)
Microparticles, Vascular Function, and Atherothrombosis
Pierre-Emmanuel Rautou et al.
CIRCULATION RESEARCH (2011)
TGF-β/TGF-β receptor system and its role in physiological and pathological conditions
Juan F. Santibanez et al.
CLINICAL SCIENCE (2011)
Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes
Jan-Malte Sinning et al.
EUROPEAN HEART JOURNAL (2011)
Circulating microparticle levels in patients with coronary artery disease: a new indicator of vulnerability?
Nicolas Amabile et al.
EUROPEAN HEART JOURNAL (2011)
Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation
John Lekakis et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2011)
Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: Relationship with oxidative stress
O. Helal et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Involvement of microparticles in diabetic vascular complications
Gala Tsimerman et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Usefulness of Soluble Endoglin as a Noninvasive Measure of Left Ventricular Filling Pressure in Heart Failure
Navin K. Kapur et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
The physiological role of endoglin in the cardiovascular system
Jose M. Lopez-Novoa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus
Bo Feng et al.
ATHEROSCLEROSIS (2010)
Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro
Fei Tian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients
Ana M. Blazquez-Medela et al.
BMC MEDICINE (2010)
Prognostic value of endothelial microparticles in patients with heart failure
Toshimitsu Nozaki et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Ultrasound Assessment of Flow-Mediated Dilation
Ryan A. Harris et al.
HYPERTENSION (2010)
Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles
Y. Yuana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Membrane microparticle determination: at least seeing what's being sized!
J. -M. Freyssinet et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Optical and non-optical methods for detection and characterization of microparticles and exosomes
E. van der Pol et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies
Arnaud Duval et al.
RHEUMATOLOGY (2010)
Overcoming Limitations of Microparticle Measurement by Flow Cytometry
Romaric Lacroix et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Signaling by members of the TGF-beta family in vascular morphogenesis and disease
Evangelia Pardali et al.
TRENDS IN CELL BIOLOGY (2010)
Circulating Endothelial Microparticles as a Marker of Cerebrovascular Disease
Keun-Hwa Jung et al.
ANNALS OF NEUROLOGY (2009)
Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT)
Sophie Bernard et al.
ATHEROSCLEROSIS (2009)
Significance of a Multiple Biomarkers Strategy Including Endothelial Dysfunction to Improve Risk Stratification for Cardiovascular Events in Patients at High Risk for Coronary Heart Disease
Toshimitsu Nozaki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Increased Expression of the Transforming Growth Factor-β Signaling Pathway, Endoglin, and Early Growth Response-1 in Stable Plaques
Pieter T. G. Bot et al.
STROKE (2009)
Assessment of Endothelial Function Using Digital Pulse Amplitude Tonometry
Naomi M. Hamburg et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2009)
Membrane vesicles as conveyors of immune responses
Clotilde Thery et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Enclothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome
Abdelali Agouni et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension
Nicolas Amabile et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Endoglin in angiogenesis and vascular diseases
Peter ten Dijke et al.
ANGIOGENESIS (2008)
S-Endoglin Expression Is Induced in Senescent Endothelial Cells and Contributes to Vascular Pathology
Francisco J. Blanco et al.
CIRCULATION RESEARCH (2008)
Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction
Ignacio Cruz-Gonzalez et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Tissue factor-bearing microparticles and cancer
Jeffrey I. Zwicker
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Novel biochemical pathways of endoglin in vascular cell physiology
Carmelo Bernabeu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease
Chantal M. Boulanger et al.
HYPERTENSION (2007)
Endothelial function and dysfunction - Testing and clinical relevance
John E. Deanfield et al.
CIRCULATION (2007)
Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes
Maarten E. Tushuizen et al.
DIABETES CARE (2007)
Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-β signaling
Juan F. Santibanez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Endothelial microparticles correlate with endothelial dysfunction in obese women
Katherine Esposito et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Circulating microparticles - A potential prognostic marker for atherosclerotic vascular disease
Chantal M. Boulanger et al.
HYPERTENSION (2006)
Significant expression of endoglin (CD105), TGFβ-1 and TGFβR-2 in the atherosclerotic aorta:: An immunohistological study
M Piao et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2006)
Reduced angiogenic responses in adult endoglin heterozygous mice
M Jerkic et al.
CARDIOVASCULAR RESEARCH (2006)
Endocan, a new endothelial marker in human sepsis
A Scherpereel et al.
CRITICAL CARE MEDICINE (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
Circulating markers of endothelial function in cardiovascular disease
Joel Constans et al.
CLINICA CHIMICA ACTA (2006)
Circulating CD31(+) annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease
N Werner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy
S Sarrazin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2006)
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure
N Amabile et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress
A Mezentsev et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease
H Koga et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus
JB Meigs et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Endothelial and platelet microparticles in vasculitis of the young
PA Brogan et al.
ARTHRITIS AND RHEUMATISM (2004)
Endothelial dysfunction and damage in congestive heart failure - Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide
AY Chong et al.
CIRCULATION (2004)
Endoglin regulates nitric oxide-dependent vasodilatation
M Jerkic et al.
FASEB JOURNAL (2004)
Endothelium-derived microparticles impair endothelial function in vitro
SV Brodsky et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation
JJ Jimenez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Endothelial function testing as a biomarker of vascular disease
S Verma et al.
CIRCULATION (2003)
Clinical utility of endothelial function testing - Ready for prime time?
JT Kuvin et al.
CIRCULATION (2003)
High levels of circulating endothelial microparticles in patients with acute coronary syndromes
L Bernal-Mizrachi et al.
AMERICAN HEART JOURNAL (2003)
Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis
JJ Jimenez et al.
THROMBOSIS RESEARCH (2003)
Endothelial dysfunction - A marker of atherosclerotic risk
PO Bonetti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Effects of severe hypertension on endothelial and platelet microparticles
RA Preston et al.
HYPERTENSION (2003)
Inducible expression of human endoglin during inflammation and wound healing in vivo
E Torsney et al.
INFLAMMATION RESEARCH (2002)
Type 1 and type 2 diabetic patients display different patterns of cellular microparticles
F Sabatier et al.
DIABETES (2002)
Fundamentals of endothelial function for the clinical cardiologist
S Verma et al.
CIRCULATION (2002)
Low TGF-beta 1 serum levels are a risk factor for atherosclerosis disease in ESRD patients
S Stefoni et al.
KIDNEY INTERNATIONAL (2002)
Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction
CM Boulanger et al.
CIRCULATION (2001)
Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1
D Béchard et al.
JOURNAL OF IMMUNOLOGY (2001)
Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques
BA Conley et al.
ATHEROSCLEROSIS (2000)
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
Z Mallat et al.
CIRCULATION (2000)
The significance of CD105, TGF beta and CD105/TGF beta complexes in coronary artery disease
CG Li et al.
ATHEROSCLEROSIS (2000)
分享论文
